SEC Form 4 · accession 0001214659-16-012178
Anthera Pharmaceuticals Inc · ANTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles V Olson
Officer — CHIEF TECHNOLOGY OFFICER
Period of report
Jun 9, 2016
Accepted (ET)
Jun 13, 2016 · 7:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001316175
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $3.52 | Jun 9, 2016 | A | 100,000 | A | — | Jun 9, 2026 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1This stock option vests monthly over four years beginning January 1, 2016 (the Vesting Start Date). The Stock Option is completely vested on the fourth anniversary of the vesting start date and will expire on June 9, 2026.